|
MedChemExpress
mg 132 Mg 132, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mg 132/product/MedChemExpress Average 99 stars, based on 1 article reviews
mg 132 - by Bioz Stars,
2026-02
99/100 stars
|
Buy from Supplier |
|
MedChemExpress
(r)-mg-132 (R) Mg 132, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/(r)-mg-132/product/MedChemExpress Average 94 stars, based on 1 article reviews
(r)-mg-132 - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
mg132 ![]() Mg132, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mg132/product/MedChemExpress Average 97 stars, based on 1 article reviews
mg132 - by Bioz Stars,
2026-02
97/100 stars
|
Buy from Supplier |
|
MedChemExpress
inclisiran ![]() Inclisiran, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/inclisiran/product/MedChemExpress Average 94 stars, based on 1 article reviews
inclisiran - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
26s proteasome inhibitor ![]() 26s Proteasome Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/26s proteasome inhibitor/product/MedChemExpress Average 90 stars, based on 1 article reviews
26s proteasome inhibitor - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
MedChemExpress
pmsf ![]() Pmsf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pmsf/product/MedChemExpress Average 98 stars, based on 1 article reviews
pmsf - by Bioz Stars,
2026-02
98/100 stars
|
Buy from Supplier |
|
MedChemExpress
necrostatin 1 ![]() Necrostatin 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/necrostatin 1/product/MedChemExpress Average 99 stars, based on 1 article reviews
necrostatin 1 - by Bioz Stars,
2026-02
99/100 stars
|
Buy from Supplier |
|
Teprasiran sodium is a small interfering RNA that temporarily inhibits p53-mediated cell death that underlies acute kidney injury (AKI).
|
Buy from Supplier |
Image Search Results
Journal: PLOS Pathogens
Article Title: A novel SO 2 probe inhibits lysophagy induced by Senecavirus A infection by promoting LAMP1 Cys375 sulfenylation
doi: 10.1371/journal.ppat.1013932
Figure Lengend Snippet: (A) The ubiquitination level of LAMP1 treated with CQ (10 μM) and MG132 (50 nM) before and after SVA infection. (B,C) Effect of CQ (50 μM) and MG132 (50 nM) on LAMP1 protein levels before and after SVA infection. (D,E) Effects of DLC alone or in combination with MG132 (50 nM) on LAMP1 protein levels after SVA infection. (F) Effect of DLC on the interaction between endogenous TRIM16 and Gal3 in SVA infected cells by Co-IP (After Gal protein was immunoprecipitated, Gal3 and TRIM16 proteins were respectively used for detection). (G,H) Colocalization changes of TRIM16 and Gal3 in cells with and without DLC (5 μM) after SVA infection (0.01MOI, 24 hpi) and quantitative analysis.(*p < 0.05, **p < 0.01, ***p < 0.001, n = 3).
Article Snippet: Chemical reagents LAMP1,
Techniques: Ubiquitin Proteomics, Infection, Co-Immunoprecipitation Assay, Immunoprecipitation
Journal: medRxiv
Article Title: Spatially resolved proteomic signatures of atherosclerotic carotid artery disease
doi: 10.1101/2025.02.09.25321955
Figure Lengend Snippet: A , Experimental workflow for characterising inflammatory and oxidative stress in VSMCs. B . PCSK9 protein abundance (log2 MS intensity) in observed (dark dots) and imputed (light dots) samples across conditions, with statistical comparisons shown. C , Knowledge-graph analysis of POVPC-induced gene expression changes; D , Pathway activation analysis comparing control (ethanol, grey), POVPC treatment (red) and PCSK9 knockdown (Inclisiran, blue) effects.
Article Snippet: Subsequently, 25 nM
Techniques: Expressing, Activation Assay, Control, Knockdown
Journal: medRxiv
Article Title: Spatially resolved proteomic signatures of atherosclerotic carotid artery disease
doi: 10.1101/2025.02.09.25321955
Figure Lengend Snippet: A , Number of proteins quantified in cellular proteome (orange) and secretome (green) across experimental conditions. B , Principal component analysis of cellular proteome and secretome samples showing separation of treatment conditions. C-D , Volcano plots showing differentially expressed proteins (red dots, p < 0.05) in response to D, POVPC treatment and E, PCSK9 knockdown compared to controls (siNEG). E , Integrated knowledge graph analysis of proteins significantly upregulated upon PCSK9 knockdown with Inclisiran (red: upregulated, blue: downregulated).
Article Snippet: Subsequently, 25 nM
Techniques: Knockdown
Journal: Frontiers in Pharmacology
Article Title: Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α
doi: 10.3389/fphar.2023.1138265
Figure Lengend Snippet: Analysis of apoptosis in NC, TQ-, GEM-, TQ + GEM-, and TQ + GEM + MG132-treated PANC-1 cells under hypoxic conditions ( n = 3).
Article Snippet: TQ (HY-D0803, MCE); GEM (HY-17026, MCE); dimethyl sulfoxide (Sigma); fetal bovine serum (GIBCO), RPMI-1640 medium (GIBCO); primary antibodies including anti-COL1A1 (67288-1-Ig, PROTEINTECH), anti-COL3A1 (22734-1-AP, PROTEINTECH), anti-COL5A1 (67604-1-Ig, PROTEINTECH), anti-HIF-1α (20960-1-AP, PROTEINTECH), anti-OH-HIF-1α (3434T, CST), anti-TGFβ1 (21898-1-AP, PROTEINTECH), anti-Smad2 (12570-1-AP, PROTEINTECH), anti-Smad3 (66516-1-Ig, PROTEINTECH); hTGFβ (HY-P70543, MCE); LY2157299 (HY-13226, MCE); PX-478 (HY-10231, MCE);
Techniques:
Journal: Frontiers in Pharmacology
Article Title: Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α
doi: 10.3389/fphar.2023.1138265
Figure Lengend Snippet: TQ and GEM affect cell apoptosis and motility in PC cells under hypoxic conditions. (A) Transwell (migration and invasion) of NC, TQ-, GEM-, TQ + GEM-, and TQ + GEM + MG132-treated PANC-1 cells under hypoxic conditions. (B) Statistical analysis of Figure 6 (apoptosis analysis). (C) Statistical analysis of (A) (transwell migration). (D) Statistical analysis of (A) (transwell invasion). * p < 0.05 compared with NC; # p < 0.05 compared with TQ or GEM; and p < 0.05 compared with TQ + GEM ( n = 3).
Article Snippet: TQ (HY-D0803, MCE); GEM (HY-17026, MCE); dimethyl sulfoxide (Sigma); fetal bovine serum (GIBCO), RPMI-1640 medium (GIBCO); primary antibodies including anti-COL1A1 (67288-1-Ig, PROTEINTECH), anti-COL3A1 (22734-1-AP, PROTEINTECH), anti-COL5A1 (67604-1-Ig, PROTEINTECH), anti-HIF-1α (20960-1-AP, PROTEINTECH), anti-OH-HIF-1α (3434T, CST), anti-TGFβ1 (21898-1-AP, PROTEINTECH), anti-Smad2 (12570-1-AP, PROTEINTECH), anti-Smad3 (66516-1-Ig, PROTEINTECH); hTGFβ (HY-P70543, MCE); LY2157299 (HY-13226, MCE); PX-478 (HY-10231, MCE);
Techniques: Migration
Journal: Frontiers in Pharmacology
Article Title: Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α
doi: 10.3389/fphar.2023.1138265
Figure Lengend Snippet: TQ might affect GEM sensitivity by regulating ECM production in PC cells under hypoxic conditions. (A) Western blot of HIF-1α in NC, TQ-, GEM-, TQ + GEM-, and TQ + GEM + MG132-treated PANC-1 cells under hypoxic conditions. (B) Western blot of ECM production-related proteins and TGFβ1 in NC, TQ-, GEM-, TQ + GEM-, and TQ + GEM + MG132-treated PANC-1 cells under hypoxic conditions. (C) Statistical analysis of (A , B) . * p < 0.05 compared with NC; # p < 0.05 compared with TQ or GEM; and p < 0.05 compared with TQ + GEM ( n = 3).
Article Snippet: TQ (HY-D0803, MCE); GEM (HY-17026, MCE); dimethyl sulfoxide (Sigma); fetal bovine serum (GIBCO), RPMI-1640 medium (GIBCO); primary antibodies including anti-COL1A1 (67288-1-Ig, PROTEINTECH), anti-COL3A1 (22734-1-AP, PROTEINTECH), anti-COL5A1 (67604-1-Ig, PROTEINTECH), anti-HIF-1α (20960-1-AP, PROTEINTECH), anti-OH-HIF-1α (3434T, CST), anti-TGFβ1 (21898-1-AP, PROTEINTECH), anti-Smad2 (12570-1-AP, PROTEINTECH), anti-Smad3 (66516-1-Ig, PROTEINTECH); hTGFβ (HY-P70543, MCE); LY2157299 (HY-13226, MCE); PX-478 (HY-10231, MCE);
Techniques: Western Blot